MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$1,600,751
(40.86%↑ Y/Y)
Net loss
attributable to lexaria...
-$1,595,007
(41.01%↑ Y/Y)
Foreign currency
translation adjustment
-$5,744
(-80.91%↓ Y/Y)
Less net loss
attributable to...
-$2,496
(14.78%↑ Y/Y)
Net loss
-$1,597,503
(40.98%↑ Y/Y)
Net loss before
income taxes
-$1,595,712
Income taxes
$1,791
Loss from operations
-$1,573,631
(41.52%↑ Y/Y)
Total other income
(gain)
-$22,081
Interest income
$12
(9.09%↑ Y/Y)
Total operating
expenses
$1,573,631
(-45.21%↓ Y/Y)
Unrealized gain on
marketable securities
-$22,093
(-38.67%↓ Y/Y)
General and
administrative
$902,291
(-1.79%↓ Y/Y)
Research and development
$671,340
(-65.63%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Corp. (LEXX)